#San Diego #Class Action #United Kingdom #Reckitt Benckiser #Enfamil

Robbins LLP Updates Investors on Class Action Against Reckitt Benckiser Group PLC

In a significant legal development, Robbins LLP has announced that a class action lawsuit has been initiated against Reckitt Benckiser Group PLC (OTC RBGLY) on behalf of stockholders who invested in the company between January 13, 2021, and July 28, 2024. Reckitt Benckiser is a UK-based consumer goods powerhouse known for its diverse product lines across hygiene, health, and nutrition segments.

Allegations Against Reckitt Benckiser

The core of the complaint revolves around allegations that Reckitt misled its shareholders by not adequately informing them about the potential health risks associated with its baby formula, Enfamil. Specifically, the lawsuit highlights that the company failed to disclose crucial information regarding the heightened risk of necrotizing enterocolitis (NEC) for preterm infants consuming their cow's milk-based formula.

Legal Precedent

This lawsuit follows earlier legal verdicts that have raised alarms about Reckitt's accountability. Notably, on March 15, 2024, a jury in St. Clair County, Illinois ruled in favor of the plaintiffs in a case linked to NEC, awarding $60 million in damages. The jury found that Mead Johnson, a subsidiary of Reckitt, was negligent in not warning a mother about the risks posed to her preterm infant. This verdict caused a significant stock price drop for Reckitt Benckiser, with shares falling nearly 14% following the ruling.

Moreover, a similar verdict was passed in another case on July 29, 2024, which found that Abbott Laboratories' formula similarly endangered the health of infants. This ruling also affected Reckitt's stock price, resulting in another notable decline of approximately 9%. Such legal precedents have substantial implications for Reckitt Benckiser's product safety claims and the reliability of its financial disclosures.

What Investors Need to Know

For those holding shares in Reckitt Benckiser, this class action suits opens opportunities to claim potential recoveries for losses incurred during the specified period. Shareholders interested in leading the litigation as principal plaintiffs must file by August 4, 2025. Being a lead plaintiff means actively representing the interests of other shareholders who may also be affected by this lawsuit.

Investors can opt to remain passive members of this class action without facing additional participation burdens if they choose not to be involved. Furthermore, Robbins LLP asserts that all representations in this case will be on a contingency basis, meaning that shareholders will incur no legal fees unless successful in recovering damages.

About Robbins LLP

Robbins LLP has built a reputation for advocating shareholder rights since 2002, focusing on helping investors recover misadvised losses and improve governance standards within corporations. The firm's commitment to holding executives accountable for alleged wrongdoing remains a cornerstone of its operations.

Stay Informed

To keep abreast of developments regarding this class action and other shareholder-related issues, interested parties are encouraged to sign up for updates via Stock Watch. Ensuring that shareholders are informed about key happenings is part of Robbins LLP's mission to promote transparency and engagement in corporate governance.

Investors are reminded that previous case results do not guarantee a predictable outcome in this or any future litigation, emphasizing the inherent risks involved in such legal endeavors.

For further details or to discuss participation in the class action, investors can reach Robbins LLP through their official communications channels.

• ---